Copyright Reports & Markets. All rights reserved.

Global Trastuzumab Biosimilars Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Trastuzumab Biosimilars
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Trastuzumab Biosimilars Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Humanized Trastuzumab
    • 1.3.3 Animal-derived Trastuzumab
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Trastuzumab Biosimilars Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
  • 1.5 Global Trastuzumab Biosimilars Market Size & Forecast
    • 1.5.1 Global Trastuzumab Biosimilars Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Trastuzumab Biosimilars Sales Quantity (2018-2029)
    • 1.5.3 Global Trastuzumab Biosimilars Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Fosun International Limited
    • 2.1.1 Fosun International Limited Details
    • 2.1.2 Fosun International Limited Major Business
    • 2.1.3 Fosun International Limited Trastuzumab Biosimilars Product and Services
    • 2.1.4 Fosun International Limited Trastuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Fosun International Limited Recent Developments/Updates
  • 2.2 Anhui Anke Bioengineering
    • 2.2.1 Anhui Anke Bioengineering Details
    • 2.2.2 Anhui Anke Bioengineering Major Business
    • 2.2.3 Anhui Anke Bioengineering Trastuzumab Biosimilars Product and Services
    • 2.2.4 Anhui Anke Bioengineering Trastuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Anhui Anke Bioengineering Recent Developments/Updates
  • 2.3 Hisun Biopharmaceuticals
    • 2.3.1 Hisun Biopharmaceuticals Details
    • 2.3.2 Hisun Biopharmaceuticals Major Business
    • 2.3.3 Hisun Biopharmaceuticals Trastuzumab Biosimilars Product and Services
    • 2.3.4 Hisun Biopharmaceuticals Trastuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Hisun Biopharmaceuticals Recent Developments/Updates
  • 2.4 Chia Tai Tianqing Pharmaceutical Group
    • 2.4.1 Chia Tai Tianqing Pharmaceutical Group Details
    • 2.4.2 Chia Tai Tianqing Pharmaceutical Group Major Business
    • 2.4.3 Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Product and Services
    • 2.4.4 Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
  • 2.5 Genentech Inc
    • 2.5.1 Genentech Inc Details
    • 2.5.2 Genentech Inc Major Business
    • 2.5.3 Genentech Inc Trastuzumab Biosimilars Product and Services
    • 2.5.4 Genentech Inc Trastuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Genentech Inc Recent Developments/Updates
  • 2.6 Daiichi Sankyo
    • 2.6.1 Daiichi Sankyo Details
    • 2.6.2 Daiichi Sankyo Major Business
    • 2.6.3 Daiichi Sankyo Trastuzumab Biosimilars Product and Services
    • 2.6.4 Daiichi Sankyo Trastuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Daiichi Sankyo Recent Developments/Updates
  • 2.7 Pfizer
    • 2.7.1 Pfizer Details
    • 2.7.2 Pfizer Major Business
    • 2.7.3 Pfizer Trastuzumab Biosimilars Product and Services
    • 2.7.4 Pfizer Trastuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Pfizer Recent Developments/Updates
  • 2.8 Celltrion Healthcare
    • 2.8.1 Celltrion Healthcare Details
    • 2.8.2 Celltrion Healthcare Major Business
    • 2.8.3 Celltrion Healthcare Trastuzumab Biosimilars Product and Services
    • 2.8.4 Celltrion Healthcare Trastuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Celltrion Healthcare Recent Developments/Updates
  • 2.9 Baxter Oncology GmbH
    • 2.9.1 Baxter Oncology GmbH Details
    • 2.9.2 Baxter Oncology GmbH Major Business
    • 2.9.3 Baxter Oncology GmbH Trastuzumab Biosimilars Product and Services
    • 2.9.4 Baxter Oncology GmbH Trastuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Baxter Oncology GmbH Recent Developments/Updates
  • 2.10 Sandoz
    • 2.10.1 Sandoz Details
    • 2.10.2 Sandoz Major Business
    • 2.10.3 Sandoz Trastuzumab Biosimilars Product and Services
    • 2.10.4 Sandoz Trastuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Sandoz Recent Developments/Updates

3 Competitive Environment: Trastuzumab Biosimilars by Manufacturer

  • 3.1 Global Trastuzumab Biosimilars Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Trastuzumab Biosimilars Revenue by Manufacturer (2018-2023)
  • 3.3 Global Trastuzumab Biosimilars Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Trastuzumab Biosimilars by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Trastuzumab Biosimilars Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Trastuzumab Biosimilars Manufacturer Market Share in 2022
  • 3.5 Trastuzumab Biosimilars Market: Overall Company Footprint Analysis
    • 3.5.1 Trastuzumab Biosimilars Market: Region Footprint
    • 3.5.2 Trastuzumab Biosimilars Market: Company Product Type Footprint
    • 3.5.3 Trastuzumab Biosimilars Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Trastuzumab Biosimilars Market Size by Region
    • 4.1.1 Global Trastuzumab Biosimilars Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Trastuzumab Biosimilars Consumption Value by Region (2018-2029)
    • 4.1.3 Global Trastuzumab Biosimilars Average Price by Region (2018-2029)
  • 4.2 North America Trastuzumab Biosimilars Consumption Value (2018-2029)
  • 4.3 Europe Trastuzumab Biosimilars Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Trastuzumab Biosimilars Consumption Value (2018-2029)
  • 4.5 South America Trastuzumab Biosimilars Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Trastuzumab Biosimilars Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Trastuzumab Biosimilars Sales Quantity by Type (2018-2029)
  • 5.2 Global Trastuzumab Biosimilars Consumption Value by Type (2018-2029)
  • 5.3 Global Trastuzumab Biosimilars Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Trastuzumab Biosimilars Sales Quantity by Application (2018-2029)
  • 6.2 Global Trastuzumab Biosimilars Consumption Value by Application (2018-2029)
  • 6.3 Global Trastuzumab Biosimilars Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Trastuzumab Biosimilars Sales Quantity by Type (2018-2029)
  • 7.2 North America Trastuzumab Biosimilars Sales Quantity by Application (2018-2029)
  • 7.3 North America Trastuzumab Biosimilars Market Size by Country
    • 7.3.1 North America Trastuzumab Biosimilars Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Trastuzumab Biosimilars Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Trastuzumab Biosimilars Sales Quantity by Type (2018-2029)
  • 8.2 Europe Trastuzumab Biosimilars Sales Quantity by Application (2018-2029)
  • 8.3 Europe Trastuzumab Biosimilars Market Size by Country
    • 8.3.1 Europe Trastuzumab Biosimilars Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Trastuzumab Biosimilars Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Trastuzumab Biosimilars Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Trastuzumab Biosimilars Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Trastuzumab Biosimilars Market Size by Region
    • 9.3.1 Asia-Pacific Trastuzumab Biosimilars Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Trastuzumab Biosimilars Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Trastuzumab Biosimilars Sales Quantity by Type (2018-2029)
  • 10.2 South America Trastuzumab Biosimilars Sales Quantity by Application (2018-2029)
  • 10.3 South America Trastuzumab Biosimilars Market Size by Country
    • 10.3.1 South America Trastuzumab Biosimilars Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Trastuzumab Biosimilars Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Trastuzumab Biosimilars Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Trastuzumab Biosimilars Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Trastuzumab Biosimilars Market Size by Country
    • 11.3.1 Middle East & Africa Trastuzumab Biosimilars Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Trastuzumab Biosimilars Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Trastuzumab Biosimilars Market Drivers
  • 12.2 Trastuzumab Biosimilars Market Restraints
  • 12.3 Trastuzumab Biosimilars Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Trastuzumab Biosimilars and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Trastuzumab Biosimilars
  • 13.3 Trastuzumab Biosimilars Production Process
  • 13.4 Trastuzumab Biosimilars Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Trastuzumab Biosimilars Typical Distributors
  • 14.3 Trastuzumab Biosimilars Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Trastuzumab Biosimilars market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
    Trastuzumab is used for the treatment of HER2-positive early breast cancer, metastatic breast cancer and metastatic gastric cancer.
    The Global Info Research report includes an overview of the development of the Trastuzumab Biosimilars industry chain, the market status of Hospital (Humanized Trastuzumab, Animal-derived Trastuzumab), Clinic (Humanized Trastuzumab, Animal-derived Trastuzumab), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Trastuzumab Biosimilars.
    Regionally, the report analyzes the Trastuzumab Biosimilars markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Trastuzumab Biosimilars market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Trastuzumab Biosimilars market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Trastuzumab Biosimilars industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Humanized Trastuzumab, Animal-derived Trastuzumab).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Trastuzumab Biosimilars market.
    Regional Analysis: The report involves examining the Trastuzumab Biosimilars market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Trastuzumab Biosimilars market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Trastuzumab Biosimilars:
    Company Analysis: Report covers individual Trastuzumab Biosimilars manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Trastuzumab Biosimilars This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
    Technology Analysis: Report covers specific technologies relevant to Trastuzumab Biosimilars. It assesses the current state, advancements, and potential future developments in Trastuzumab Biosimilars areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Trastuzumab Biosimilars market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Trastuzumab Biosimilars market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Humanized Trastuzumab
    Animal-derived Trastuzumab
    Market segment by Application
    Hospital
    Clinic
    Major players covered
    Fosun International Limited
    Anhui Anke Bioengineering
    Hisun Biopharmaceuticals
    Chia Tai Tianqing Pharmaceutical Group
    Genentech Inc
    Daiichi Sankyo
    Pfizer
    Celltrion Healthcare
    Baxter Oncology GmbH
    Sandoz
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Trastuzumab Biosimilars product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Trastuzumab Biosimilars, with price, sales, revenue and global market share of Trastuzumab Biosimilars from 2018 to 2023.
    Chapter 3, the Trastuzumab Biosimilars competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Trastuzumab Biosimilars breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Trastuzumab Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Trastuzumab Biosimilars.
    Chapter 14 and 15, to describe Trastuzumab Biosimilars sales channel, distributors, customers, research findings and conclusion.

    Buy now